New Laser-Like eye surgery device falls short – trial stopped early
NCT ID NCT05713253
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called the ELITA System to reduce or eliminate nearsightedness (myopia) and astigmatism. It involved 96 adults aged 22 and older who received a lenticule removal procedure in one or both eyes. The trial was terminated early, so the planned results on safety and vision improvement are not fully available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ELITA System (a device for lenticule removal surgery)
What this could lead to
If successful, this could offer a new surgical option to correct nearsightedness and astigmatism, potentially reducing dependence on glasses or contacts.
What could go wrong
The trial was terminated early, so we don't have full safety and effectiveness data. As with any eye surgery, risks include infection, under- or over-correction, and vision changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTIVE ERROR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoopes, Durrie, Rivera Research, LLC
Draper, Utah, 84020, United States
-
Stanford Eye Laser Center
Palo Alto, California, 94303, United States